Sarepta Therapeutics Inc (SRPT) Habari na Bei za Hisa

MwanzoSRPT • NASDAQ

Sarepta Therapeutics Inc

$ 18.02

5 Nov, 10:08:29 GMT -5 · USD · NASDAQ · Kanusho

HisaHisa zinazouzwa Marekani

Bei iliyotangulia

$ 16.20

Bei za siku

$ 16.58 - $ 18.15

Bei za mwaka

$ 10.42 - $ 138.69

Thamani ya kampuni katika soko

1.82B USD

Wastani wa hisa zilizouzwa

6.16M

Uwiano wa bei na mapato

Mgao wa faida

Ubadilishanaji wa msingi

NASDAQ

Kwenye habari

Yahoo Finance

siku 1 iliyopita

Sarepta Therapeutics Inc (SRPT) Q3 2025 Earnings Call Highlights: Resilient Revenue Amidst ...

Seeking Alpha

siku 1 iliyopita

FDA Duchenne Failure Hits Sarepta Amid 3Q25 Earnings Beat (NASDAQ:SRPT)

MarketBeat

saa 17 zilizopita

Sarepta Therapeutics (NASDAQ:SRPT) Releases Quarterly Earnings Results, Misses Expectations By $0.15 EPS

Nasdaq

saa 18 zilizopita

Noteworthy Tuesday Option Activity: MDGL, HOG, SRPT

Investing.com

siku 1 iliyopita

Sarepta stock plunges after ESSENCE trial misses primary endpoint

Schaeffer's Investment Research

saa 22 zilizopita

Sarepta Therapeutics Stock Tumbles After Trial Data

Kuhusu

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia

Afisa Mkuu Mtendaji (CEO)

Douglas S. Ingram

Ilianzishwa

1980

Tovuti

sarepta.com

Wafanyakazi

1,372